Age

Age-related macular degeneration is the most common cause for the loss of central seeing with humans beyond the age of 50 in the industrial nations. A triplication of the patients is expected in the next 25 years. Especially in the last couple of years the standard of knowledge regarding etiology, risk factors, diagnostics and therapy of this retina illness has substantially grown which is presented in this up-to-date multi-authored work. Apart from epidemiologically identified risk factors both the various pathophysiological aspects and clinical manifestations and angiographic characteristics are clearly represented and in line with standard usage. Furthermore, the different therapeutic approaches are treated, which include proven procedures as laser therapy and seeing-aids systems, in addition to latest methods in the area of the pharmacology, the photo-dynamic therapy, transpupil thermal therapy (TTT) and the macular surgery. The volume is well-illustrated and tables and summaries round up the representation.